XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net loss $ (6,980) $ (3,623)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 73 81
Share-based compensation 419 42
Non-cash interest expense 32 42
Changes in operating assets and liabilities:    
Accounts receivable (257) 60
Prepaid expenses and other assets (534) (63)
Deferred revenue 0 (173)
Accounts payable 118 235
Accrued liabilities (1,054) (771)
Net cash used in operating activities (8,183) (4,170)
Cash flows from investing activities:    
Cash acquired in reverse merger 1,280 0
Purchases of property and equipment (44) (105)
Net cash provided by (used in) investing activities 1,236 (105)
Cash flows from financing activities:    
Proceeds from the sale of common stock 40,703 0
Payment of issuance costs associated with the sale of common stock (1,176) 0
Payment of principal of notes payable (500) 0
Proceeds from the exercise of stock options 89 0
Net cash provided by financing activities 39,116 0
Net increase (decrease) in cash and cash equivalents 32,169 (4,275)
Cash and cash equivalents at beginning of period 22,104 21,235
Cash and cash equivalents at end of period 54,273 16,960
Supplemental disclosure of cash flow information    
Interest paid 38 41
Supplemental disclosure of non-cash investing and financing activities    
Conversion of preferred stock to common stock 76,981 0
Liabilities assumed, net of non-cash assets received in reverse merger 1,076 0
Transfer of common stock issuance costs from prepaid expenses and other current assets to equity 331 0
Unpaid financing costs included in prepaid expenses and other current assets and accrued liabilities 184 0
Unpaid common stock issuance costs included in accrued liabilities 40 0
Reclassification of preferred stock warrant to common stock warrant 51 0
Accretion of offering costs $ 5 $ 12